Transcriptomic and Network Analysis Highlight the Association of Diabetes at Different Stages of Alzheimer’s Disease
Alzheimer’s disease (AD) and type 2 diabetes (T2D) are among the most prevalent chronic diseases affecting the aging population. Extensive research evidence indicates that T2D is a well-established risk factor for AD; however, the molecular mechanisms underlying this association have not been fully...
Main Authors: | Jose A. Santiago, Virginie Bottero, Judith A. Potashkin |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Neuroscience |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fnins.2019.01273/full |
Similar Items
-
Meta-Analysis of Gene Expression Changes in the Blood of Patients with Mild Cognitive Impairment and Alzheimer’s Disease Dementia
by: Virginie Bottero, et al.
Published: (2019-10-01) -
Clinical Applicability of the Specific Risk Score of Dementia in Type 2 Diabetes in the Identification of Patients with Early Cognitive Impairment: Results of the MOPEAD Study in Spain
by: Angel Michael Ortiz Zuñiga, et al.
Published: (2020-08-01) -
Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment
by: Claudia Cicognola, et al.
Published: (2021-03-01) -
Predictive Value of Routine Peripheral Blood Biomarkers in Alzheimer’s Disease
by: Xiaoyu Dong, et al.
Published: (2019-12-01) -
Comparison of performance on neuropsychological tests in amnestic Mild Cognitive Impairment and Alzheimer's disease patients
by: Patrícia Helena Figueirêdo do Vale, et al.